Silo Pharma (SILO) Retained Earnings (2019 - 2025)
Silo Pharma (SILO) has disclosed Retained Earnings for 7 consecutive years, with -$19.5 million as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 27.7% to -$19.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$19.5 million through Dec 2025, down 27.7% year-over-year, with the annual reading at -$19.5 million for FY2025, 27.7% down from the prior year.
- Retained Earnings hit -$19.5 million in Q4 2025 for Silo Pharma, down from $11345.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $26104.0 in Q1 2024 to a low of -$19.5 million in Q4 2025.
- Historically, Retained Earnings has averaged -$6.6 million across 5 years, with a median of -$5.0 million in 2022.
- Biggest YoY gain for Retained Earnings was 2838.17% in 2024; the steepest drop was 384089.48% in 2024.
- Year by year, Retained Earnings stood at -$3.3 million in 2021, then plummeted by 119.8% to -$7.2 million in 2022, then skyrocketed by 99.91% to -$6227.0 in 2023, then tumbled by 245037.16% to -$15.3 million in 2024, then dropped by 27.7% to -$19.5 million in 2025.
- Business Quant data shows Retained Earnings for SILO at -$19.5 million in Q4 2025, $11345.0 in Q3 2025, and -$17.5 million in Q2 2025.